Regulation of cyclin D1 and p16INK4A is critical for growth arrest during mammary involution

Cancer Research

Volumn 61, Issue 24, 2001, Pages 8811-8819

  Gadd, Michele ^a,b   Pisc, Carmen ^a   Branda, John ^a   Ionescu Tiba, Viviana ^a   Nikolic, Zeljko ^a,b   Yang, Chuanwei ^a   Shackleford, Gregory M ^a,e   Schmidt, Emmett V ^a,b   Wang, Timothy ^c   Cardiff, Robert D ^d  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; PROTEIN P16;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; CELL PROLIFERATION; DNA BINDING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

3T3 CELLS; ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC VECTORS; HUMANS; LACTATION; MAMMARY GLANDS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; PREGNANCY; TUMOR CELLS, CULTURED;

EID: 0035893553     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Breast cancer
2. History of breast-feeding in relation to breast cancer risk: A review of the epidemiologic literature
3. Age at any full-term pregnancy and breast cancer risk
4. Mammary gland neoplasia in long-term rodent studies
5. Susceptibility of the mammary gland to carcinogenesis. I. Differentiation of the mammary gland as determinant of tumor incidence and type of lesion
6. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development
7. Cyclin D1 provides a link between development and oncogenesis in the retina and breast
8. Chromosome 11q13 markers and D-type cyclins in breast cancer
9. Cyclin D1 (PRAD1) protein expression in breast cancer: Approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene
10. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
11. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
12. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach
13. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia
14. The E2F transcription factor is a cellular target for the RB protein
15. Retinoblastoma protein switches the E2F site from positive to negative element
16. Inhibitors of mammalian G1 cyclin-dependent kinases
17. Cancer cell cycles
18. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells
19. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer
20. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
21. Inhibitory function of p21Cip1fWAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control
22. p53-independent expression of p21cip1 in muscle and other terminally differentiating cells
23. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression
24. A novel cyclin encoded by a bcl1-linked candidate oncogene
25. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
26. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
27. Cloning and characterization of murine p16INK4a and p15INK4b genes
28. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
29. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus
30. Apoptotic cell death and tissue remodelling during mouse mammary gland involution
31. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector
32. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
33. Comparative study of human and rat mammary tumorigenesis
34. Role of the INK4a locus in tumor suppression and cell mortality
35. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
36. Effects of an Rb mutation in the mouse
37. CDK inhibitors: Positive and negative regulators of G1-phase progression
38. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development
39. INK4d-deficient mice are fertile despite testicular atrophy
40. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
41. Cooperation between the Cdk inhibitors p27 KIP1 and p57 KIP2 in the control of tissue growth and development
42. The regulation of E2F by pRB-family proteins
43. Cooperative induction of mammary tumorigenesis by TGFα and Wnts
44. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice
45. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4
46. Induction of the angiogenic phenotype by Hox D3
47. Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and cellular transformation
48. Reproductive factors and breast cancer
49. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
50. Role of hormones in mammary cancer initiation and progression